Women with OSA were more likely to report tiredness, initial insomnia, and morning headaches, and less likely to complain of typical OSA symptoms (snoring, apneas) than men.
STOP-BANG shows different discrimination power for AHI >5 and ≥30/h using RP. Five components in any combination have acceptable diagnostic S to identify patients with severe OSA. STOP-BANG performed best to identify AHI ≥30/h.
According to recent reports, sleep disorders affect 30% of the adult population
and 5-10% of children. Obstructive Sleep Apnea Hypopnea Syndrome (OSA) has a
considerable epidemiological impact and demand for consultation is growing in
our community. Therefore, it is necessary to know the principles of
interpretation of diagnostic methods. A suspicion of OSA requires confirmation.
According to the guidelines of the Argentine Association of Respiratory
Medicine, polysomnography (PSG) is the gold standard for OSA diagnosis, while
home sleep testing (HST) can be accepted as a comparatively effective method
depending on the clinical situation of the patient. This article questions the
use of AHI (apnea-hypopnea index) as the only measurement needed to diagnose OSA
and assess its severity. In fact, it is surprising that, despite the large mass
of data analyzed during sleep studies, current practices only focus on AHI. More
than four decades have passed since OSA was first described. Our tendency to
oversimplify complex conditions may prevent us from gaining a deeper and more
thorough understanding of OSA. The development and validation of OSA severity
scoring systems based on multiple parameters is still a pending issue.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.